ADVERTISEMENT

 

Point-Counterpoint

AUA2015 Webcasts

Plenary I - Sunday (traducido en español)

Point-Counterpoint: Recent Randomized Controlled Trials Have Changed my Practice

Moderator: Steven J. Skoog, MD

Debater - Pro: Antoine E. Khoury, MD, FRSC

Debater - Con: Anthony A. Caldamone, MD


Plenary I - Monday (traducido en español)

Point-Counterpoint: Refractory Overactive Bladder (OAB) with Pelvic Organ Prolapse (POP)

Moderator: Kathleen C. Kobashi, MD

Debater - Pro: E. Ann Gormley, MD

Debater - Con: Sandip P. Vasavada, MD


Point-Counterpoint: Occult SUI: What have Clinical Trials Taught Us?

Moderator: Michael E. Albo, MD

Moderator: Firouz Daneshgari, MD

Debater - Pro: Howard B. Goldman, MD

Debater - Con: Stephen R. Kraus, MD


Plenary II - Monday

Point-Counterpoint: Neoadjuvant Chemotherapy Should be the Standard in Bulky Inguinal Nodes in Penile Cancer

Moderator: Philippe E. Spiess, MD

Debater - Pro: Lance C. Pagliaro, MD

Debater - Con: Sukhbinder Minhas, MD


Point-Counterpoint: Intermittent vs. Maximal ADT: Translating Randomized Trials in Clinical Practice

Moderator: Robert C. Flanigan, MD

Debater: Maha Hussain, MD, FACP

Debater: Laurence H. Klotz, MD


Plenary I - Tuesday (traducido en español)

Point-Counterpoint: Neoadjuvant Chemotherapy for MIBC is Best

Moderator: Colin P.N. Dinney, MD

Debater - Pro: Ralph W. deVere White, MD

Debater - Con: Badrinath R. Konety, MD